Impelsys inaugurates advanced medical devices testing lab in Mangalore
Mangalore: Impelsys, a prominent global technology company, has officially launched an advanced medical device testing lab in Mangalore. Specializing in cutting-edge technologies for the healthcare industry, this new testing facility is part of Impelsys' extensive range of solutions and services, including data and analytics, AI-powered platforms, cloud services, and learning solutions.
The inauguration ceremony was led by Shyam Shetty, Managing Director of Laerdal Bangalore LLP, who expressed confidence in the success of the new testing facility. He acknowledged Impelsys' strong presence in healthcare and extended his best wishes to the team.
Shyam said that this move will also open employment opportunities for people around the city and young engineering and hospital management graduates. He further added that Mangalore is a healthcare and medical hub in the region and has potential to grow multifolds like Bengaluru.
Vincent Emerald, Global Head & Director of QA at Impelsys, shared his vision for the facility, stating that its purpose is to accelerate transformation in healthcare. The facility aims to support hospitals and wellness centers in offering safe and secure care to patients while enabling medical devices OEMs to bring their products to market more efficiently.
Vincent, during his interaction with media reporters, emphasized that the newly launched facility represents a futuristic concept within the Indian landscape. According to him, the healthcare system in the country is poised for significant evolution in the coming years, and this testing lab serves as a pivotal stepping stone in ushering in a revolutionary era for the healthcare industry.
Elaborating further, Vincent highlighted the transformative potential of the facility, stating that it aligns with the broader vision of advancing healthcare practices through cutting-edge technologies and innovative solutions. He expressed confidence that as the healthcare landscape evolves, the lab will play a crucial role in shaping the industry's trajectory, contributing to enhanced diagnostics, patient care, and overall healthcare safety.
Impelsys has positioned itself as an organization that anticipates the needs of its clients and adapts to changing trends. Recognizing the crucial role of technology in providing quality healthcare, the medical devices testing facility is designed to enhance the safety of diagnostics and patient care, a press statement from Impelsys stated.
Impelsys offers comprehensive Quality Engineering services, leveraging the fastest automation tools for both functional and non-functional testing. The QA team collaborates with global customers to ensure the delivery of high-quality, flawless products and solutions.
About Impelsys
Impelsys is a leading provider of digital transformation solutions, empowering organizations worldwide to become digital-first, data-driven intelligent enterprises. With over two decades of expertise in innovation and technology, Impelsys is a trusted partner for organizations seeking end-to-end digital advancement.
Impelsys has maintained a long-term partnership with Laerdal, a global leader in healthcare education and resuscitation training, focused on improving healthcare quality.
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
UK Oscar entry 'Santosh' in stalemate with Indian censors, release uncertain
New Delhi, Mar 27 (PTI): Globally acclaimed Hindi film "Santosh", Britain's official entry at the Oscars and one of the most talked about titles last year, may not make it to Indian theatres following hurdles in its censor certification.
Though there was no official comment from the Central Board of Film Certification (CBFC), a member termed it "a classic case of gross disagreement" between the producers and the board.
"They are unrelenting. They want zero modifications, and CBFC wants the modifications. They went to the revising committee for the second time, made more modifications, and lost their January release date... there has to be a middle ground," the member told PTI on condition of anonymity.
"Santosh", directed by British Indian filmmaker Sandhya Suri, known for documentaries such as "I For India" and "Around India with a Movie Camera",
is a police procedural thriller set in north India. The film, starring Shahana Goswami and Sunita Rajwar, was initially set for an India release on January 10.
A co-production between United Kingdom, Germany and France, it revolves around a widow who gets her late husband's job of a police constable. She and her senior inspector are soon sucked into a high profile investigation into the rape and murder of a Dalit teenager.
"Santosh" premiered in the Un Certain Regard category at the Cannes Film Festival in May last year. In India, it was showcased at the Mumbai MAMI film festival and the Dharamshala International Film Festival.
It was named UK's official Oscar entry last year but failed to make it to the final five. The film's distribution in India is being handled by PVR Inox Pictures.
In an interview with The Guardian newspaper, Suri said the censor board in India demanded radical cuts so lengthy and wide-ranging that they would be impossible to implement. She said the list of cuts included several pages and including concerns about themes relating to police conduct.
“It was very important to me that the film is released in India so I did try to figure out if there was a way to make it work,” said Suri.
“But in the end it was just too difficult to make those cuts and have a film that still made sense, let alone stayed true to its vision,” she told the newspaper.
Goswami, who plays the lead role in the movie, said she never thought it would run into a problem.
"It is disheartening... The changes are not something that we feel comfortable to make because it would alter the film. I think that's just a decision that's got made by elimination... it's nobody's desire to not have the film come out here. But at this point, that's kind of where it stands. I do feel sad about it," Goswami told PTI.
"Santosh", she said, does not target any particular person or a group but presents the reality of society.
"There's no reason why this film should create any difficulty," she said.
CBFC member, filmmaker Vivek Agnihotri, has come out in support of the movie.
"I don’t know about the cut list. I’m against banning any kind of creative work. My films have been cancelled," the director, known for controversial movies such "The Tashkent Files" and "The Kashmir Files", told PTI.
He said "Santosh" is a highly-acclaimed film and he is looking forward to watching it.
"It is a British entry to Oscar. I’ve no idea why it has been censored. It should be released in India. I’m not aware of the technicalities (of this film). We should be welcoming these films. CBFC has no mandate to ban anything; they are not a law-making authority, but they can make suggestions," Agnihotri added.
In an earlier interview with PTI, Suri had said the film's release in India is of "supreme importance" to her.
"It just ended up that I made a film on the Indian police. Actually, it is a very accessible film and the actors are so great. I had an amazing run in the cinemas in France. I did not make this film for viewers only outside of India... There are things which an Indian audience will definitely pick up that others might not," she said in October last year.
